About Spineart
Spineart is a company based in Plan-les-ouates (Switzerland) founded in 2005 by Stephane Mugnier-Jacob. Spineart has raised $116.77 million across 4 funding rounds from investors including Gimv and Ernst Göhner Stiftung. Spineart has completed 1 acquisition, including Meditech Spine. Spineart offers products and services including BAGUERA® C and PERLA® App. Spineart operates in a competitive market with competitors including GE Healthcare, Medtronic, Boston Scientific, Nevro and CONMED, among others.
- Headquarter Plan-les-ouates, Switzerland
- Founders Stephane Mugnier-Jacob
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Spineart Sa
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$116.77 M (USD)
in 4 rounds
-
Latest Funding Round
$31.3 M (USD), Series B
Sep 26, 2025
-
Investors
Gimv
& 1 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Spineart
Spineart offers a comprehensive portfolio of products and services, including BAGUERA® C and PERLA® App.
Device for treating symptomatic cervical spine disease with motion preservation.
Application for enhancing precision in spine surgery procedures.
People of Spineart
Unlock access to complete
Unlock access to complete
Funding Insights of Spineart
Spineart has successfully raised a total of $116.77M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $31.3 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $31.3M
-
First Round
First Round
(20 Sep 2016)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2025 | Amount | Series B - Spineart | Valuation |
investors |
|
| Mar, 2024 | Amount | Debt – Convertible - Spineart | Valuation |
investors |
|
| Jun, 2020 | Amount | Series B - Spineart | Valuation | Ernst Göhner |
Investors in Spineart
Spineart has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Gimv and Ernst Göhner Stiftung.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm
|
Founded Year | Domain | Location | |
|
A foundation is operated to support cultural and social initiatives.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Spineart
Spineart has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Meditech Spine.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Spinal implants are designed and developed by Meditech Spine.
|
2003 |
Financial Statements - Spineart
Spineart Comparisons
Competitors of Spineart
Spineart operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GE Healthcare, Medtronic, Boston Scientific, Nevro and CONMED, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Materials management solutions are provided for healthcare organizations.
|
|
| domain | founded_year | HQ Location |
Medical equipment for treating over 30 chronic diseases is developed.
|
|
| domain | founded_year | HQ Location |
Wide range of medical devices
|
|
| domain | founded_year | HQ Location |
Provider of high-frequency spinal cord stimulation implants
|
|
| domain | founded_year | HQ Location |
Surgical instruments are manufactured for multiple therapeutic areas.
|
|
| domain | founded_year | HQ Location |
Healthcare solutions are provided by Johnson & Johnson globally.
|
Frequently Asked Questions about Spineart
Spineart was founded in 2005 and raised its 1st funding round 11 years after it was founded.
Spineart is headquartered in Plan-les-ouates, Switzerland. It is registered at Plan-les-ouates, Geneva, Switzerland.
Spineart is a funded company, having raised a total of $116.77M across 4 funding rounds to date. The company's 1st funding round was a Series B of $51.97M, raised on Sep 20, 2016.
Spineart was founded in 2005 as a developer of medical devices in the orthopedic sector. A range of implants, including cervical cages, fixation systems, posterior and lateral titanium cages, and interspinal fusion devices, is offered for spinal and other orthopedic procedures. Instruments support arthroplasty, cervical fixation, deformity correction, interbody fusion, and thoracolumbar fixation. Certain products have obtained FDA clearance.
Spineart's top competitors include GE Healthcare, Medtronic and Boston Scientific.
Spineart offers BAGUERA® C and PERLA® App.
Spineart has made 1 acquisition, including Meditech Spine.
Spineart has 2 investors. Key investors include Gimv, and Ernst Göhner Stiftung.